Open Orphan appoints highly experienced Yamin 'Mo' Khan to the board
Open Orphan appoints highly experienced Yamin 'Mo' Khan to the board
Stay updated with breaking news from Additional Rules. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Open Orphan appoints highly experienced Yamin 'Mo' Khan to the board
Please find below our terms and conditions for use of the web site Last Updated: November 2017 This website (“ the Website“) is operated by Emap Publishing Limited, Company Number 7880758 (England) and whose registered address is c/o Metropolis International, 7th Floor, Vantage London, Great West Road, Brentford, United Kingdom, TW8 9AG (“ Emap“). Please read these Terms & Conditions carefully before using the Website. By accessing any part of the Website, you shall be deemed to have accepted these Terms & Conditions in full, regardless of whether or not you choose to register as a me...
Restart the computer. After you complete the steps, users will no longer be able to launch the application you specified. You can always repeat the steps to block access to other desktop applications. If you want to undo the changes, you can use the same instructions outlined above, but on steps 4, right-click the hash of the app currently blocked, and select the Delete option. If you are disabling applications to prevent users from making system changes, you can use these instructions to restrict access to PowerShell or Command Prompt. You can also restrict access to the Task Manager and R...
Dublin, London | 27 January 2021: Uniphar plc (the "Company" or "Uniphar") is pleased to announce the appointment of James ("Jim") Gaul and Elizabeth ("Liz") Hoctor to its Board as independent non-executive Directors with immediate effect. Jim Gaul Jim Gaul is an experienced executive and non-executive director with a strong track record in financial management in multinational pharmaceutical and healthcare sector companies. He is a former CFO of Sanofi Ireland, with thirty years' experience in companies across the healthcare value chain, from early stage/R...